CA2388308A1 - Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes - Google Patents

Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes Download PDF

Info

Publication number
CA2388308A1
CA2388308A1 CA002388308A CA2388308A CA2388308A1 CA 2388308 A1 CA2388308 A1 CA 2388308A1 CA 002388308 A CA002388308 A CA 002388308A CA 2388308 A CA2388308 A CA 2388308A CA 2388308 A1 CA2388308 A1 CA 2388308A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
sequence
seq
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388308A
Other languages
English (en)
Inventor
Klaus Ducker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388308A1 publication Critical patent/CA2388308A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des polypeptides et des polynucléotides de type GPCR_KD5 ainsi que des procédés de production de tels polypeptides au moyen de techniques de recombinaison. L'invention concerne également des procédés d'utilisation de ces polypeptides et de ces polynucléotides de type GPCR_KD5 dans des doses diagnostiques.
CA002388308A 1999-11-03 2000-10-26 Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes Abandoned CA2388308A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99121786 1999-11-03
EP99121786.0 1999-11-03
PCT/EP2000/010564 WO2001032864A2 (fr) 1999-11-03 2000-10-26 Nouveaux polypeptides de type gpcr_kd5 et sequences d'adn correspondantes

Publications (1)

Publication Number Publication Date
CA2388308A1 true CA2388308A1 (fr) 2001-05-10

Family

ID=8239324

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388308A Abandoned CA2388308A1 (fr) 1999-11-03 2000-10-26 Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes

Country Status (4)

Country Link
EP (1) EP1226250A2 (fr)
JP (1) JP2003513629A (fr)
CA (1) CA2388308A1 (fr)
WO (1) WO2001032864A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
PT1287133E (pt) * 2000-05-18 2007-03-30 Bayer Healthcare Ag Regulação do receptor acoplado à proteína g tipo dopamina humano
DE60125227T2 (de) 2000-12-01 2007-09-20 Astellas Pharma Inc. Verfahren zum screening von diabetes-heilverfahren
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
ES2499018T3 (es) 2007-09-20 2014-09-26 Irm Llc Compuestos y composiciones como moduladores de la actividad de GPR119

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289610T3 (es) * 1998-11-20 2008-02-01 Arena Pharmaceuticals, Inc. Receptor acoplado a proteina g humano huerfano rup3.
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor

Also Published As

Publication number Publication date
JP2003513629A (ja) 2003-04-15
WO2001032864A2 (fr) 2001-05-10
EP1226250A2 (fr) 2002-07-31
WO2001032864A3 (fr) 2001-12-06

Similar Documents

Publication Publication Date Title
US20070207506A1 (en) G-protein coupled receptor and DNA sequences thereof
CA2381979A1 (fr) Polypeptides pgpcr-3 et leurs sequences d'adn
CA2388308A1 (fr) Nouveaux polypeptides de type gpcr-kd5 et sequences d'adn correspondantes
US20040071695A1 (en) Novel g-protein coupled receptor
CA2389672A1 (fr) Polypeptides du type gp27 et leurs sequences d'adn
AU2001283930B2 (en) Novel g-protein coupled receptor
AU2001281836B2 (en) A g-protein coupled receptor
US20050054034A1 (en) Thyrotropin-releasing hormone receptor-like gpcr(gprfwki)
WO2001053337A1 (fr) Recepteur humain axor33 7 fois transmembranaire
US20040106149A1 (en) Novel gpcr hfrbn63
US20060154244A1 (en) Novel g-protein coupled receptor
CA2392639A1 (fr) Recepteur htogh35 couple a la proteine g
WO2001061003A1 (fr) Homologue humain du flamingo
GB2367822A (en) CD97 polypeptides
WO2001068665A1 (fr) Variant-1 du gene h3 de l'histamine humaine
CA2391504A1 (fr) Nouveaux polypeptides recepteurs olfactifs et sequences d'adn de ces polypeptides
AU2001283930A1 (en) Novel g-protein coupled receptor
AU2001281836A1 (en) A g-protein coupled receptor
WO2001014410A1 (fr) Clonage d'un recepteur 7tm de type pafr (axor11)
GB2372249A (en) G-protein coupled receptor polypeptides

Legal Events

Date Code Title Description
FZDE Discontinued